Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Long-Term Debt Issuances (2022 - 2026)

Updated

Analysis

Impact Biomedical (IBO) Long-Term Debt Issuances (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.98 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 482,000.00
Dec 31, 2024 317,000.00
Sep 30, 2024 -60,000.00
Jun 30, 2024 384,000.00
Mar 31, 2024 483,000.00
Dec 31, 2023 232,000.00
Sep 30, 2023 870,000.00
Jun 30, 2023 746,000.00
Mar 31, 2023 1.02 Mn
Dec 31, 2022 539,000.00
Sep 30, 2022 773,000.00
API Access

Impact Biomedical Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=IBO&period=max&api_key=YOUR_API_KEY